Do the 2003 ACC/ESC and 2011 ACCF/AHA risk stratification algorithms accurately distinguish high from low risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?
The 2003 ACC/ESC and 2011 ACCF/AHA risk stratification algorithms have limited power in distinguishing high from low risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
The risk of SCD increases with the aggregation of RF. The 2003 ACC/ESC and 2011 ACCF/AHA guidelines distinguish high from low risk individuals with limited power.
O’Mahony et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: